Fakultni nemocnice Bulovka
Praha 8-Liben 180 81
1 studies enrolling now · 4 studies all time
What they study most
Advanced Non Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, Melanoma, Metastatic Non Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Prostate Cancer
Studies at this site
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
- A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling
- Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling